Zoltan Oltvai, MD
|MD, Semmelweiss Medical University, Budapest|
3087 Biomedical Science Tower 3
3501 Fifth Avenue
Pittsburgh, PA 15213
Dr. Oltvai’s research interest is in the area of systems biology of cell metabolism, including the metabolism of prokaryotic and mammalian cells, including tumor cells.
Dr. Oltvai is a staff pathologist in the Division of Clinical Microbiology. He is also a faculty member of the Interdisciplinary Biomedical Science Graduate Program, the Medical Scientist Training Program, the Cellular and Molecular Pathology Graduate Training Program, and the Joint CMU-Pitt PhD Program in Computational Biology.
B Liu, Z Oltvai, H Bayir, G Silverman, S Pak, D Perlmutter, I Bahar. Quantitative Assessment Of Cell Fate Decision Between Autophagy And Apoptosis, bioRxiv, 129767 (2017). doi:10.1101/129767.
Cobanoglu MC, Oltvai ZN, Taylor DL, Bahar I (2015) BalestraWeb: efficient online evaluation of drug-target interactions Bioinformatics 31(1):131-3.
Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A, Oltvai ZN (2014) Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion Sci Rep 4:7593.